ARNA Pharma Pty,, Ltd

Form 483 issued October 17, 2025 · Frenchs Forest, Australia

Inspection
Oct 13 – Oct 17, 2025
Observations
2
Pages
4
FEI number
3007428662

In short: On October 17, 2025, FDA issued a Form 483 with 2 observations to ARNA Pharma Pty,, Ltd in Frenchs Forest, Australia (FEI 3007428662) after an inspection that ran Oct 13 – Oct 17, 2025. The investigator was Paranthaman Senthamaraikannan. Most observations concern quality system and facilities & equipment; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

Quality system and facilities & equipment account for 2 of 2 observations.

Quality system1
Facilities & equipment1

Most cited: 21 CFR 211.192 (1×) · 211.68(b) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…

  2. 02

    Appropriate controls are not exercised over computers or related systems to assure that changes in master…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at ARNA Pharma Pty,, Ltd?

FDA listed 2 observations on this Form 483, mostly about quality system and facilities & equipment. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected ARNA Pharma Pty,, Ltd?

Paranthaman Senthamaraikannan is named on this Form 483, for the inspection of Oct 13 – Oct 17, 2025. Each investigator has a profile showing what they cite most.

When was ARNA Pharma Pty,, Ltd inspected by FDA?

The inspection ran Oct 13 – Oct 17, 2025, and the Form 483 is dated October 17, 2025.

How do I get the full Form 483 for ARNA Pharma Pty,, Ltd?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free